BiopharmaTrend.com

NuMedii

NuMedii

Private company
NUMEDII

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.


Founded
2008
Status
Private company
Geography
United States of America based
Funding
$5.500 M
Patents
1
Research papers
14

Products

AIDD

NuMedii has built a powerful technology, AIDD (Artificial Intelligence for Drug Discovery) that harnesses Big Data and AI to rapidly …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page